HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Kao acquires Kanebo

This article was originally published in The Rose Sheet

Executive Summary

Japanese company purchases Kanebo for approximately $2.37 bil. (¥1=$.0084) in stock, Kao announces Dec. 16. Company will acquire $2.24 bil. in stock from Japan's Industrial Revitalization Corporation Jan. 31 and $132.6 mil. in stock from Kanebo in mid-February, firm notes. Acquisition aims to "create one of the world's foremost cosmetics business groups," according to Kao. Kanebo will become a wholly owned subsidiary but will remain an "independent organization" with no changes to management, Kao adds. Firm was in talks to buy Kanebo in 2004, but bowed out of negotiations, after which the company was taken over by government-run IRCJ (1"The Rose Sheet" March 1, 2004, In Brief and 2"The Rose Sheet" May 17, 2004, In Brief). Kanebo generated net sales of $1.3 bil. in the nine months ended Sept. 30, and is expected to achieve sales of $1.7 bil. for the year ended Dec. 31, Kao says...

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS013604

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel